Abstract
Growing evidence suggests that some individuals may exhibit symptoms of dependence to ultraviolet light, a known carcinogen, in the context of tanning. Genetic associations with tanning dependence (TD) have not yet been explored. We conducted an exome-wide association study in 79 individuals who exhibited symptoms of TD and 213 individuals with volitional exposure to ultraviolet light, but who were not TD based on three TD scales. 300,000 mostly exomic single nucleotide polymorphisms primarily in coding regions were assessed using an Affymetrix Axiom Array. We performed a gene burden test with Bonferroni correction for the number of genes examined (p<0.05/14,904 = 3.36×10−6). One gene, Patched Domain Containing 2 (PTCHD2), yielded a statistically significant p-value of 2.5×10−6 (OR = 0.27) with fewer individuals classified as TD having a minor allele at this locus. These results require replication, but are the first to support a specific genetic association with TD.
Background
Recent research involving volitional tanners indicates the presence of behaviors and symptoms that generally fulfill criteria for dependence, and defines tanning dependence (TD) analogous to substance dependence. These behaviors are characterized by continued and frequent tanning despite adverse consequences, such as skin cancer (1), or tanning with greater frequency than required to maintain a tan. In addition, withdrawal symptoms have been reported in frequent, but not infrequent, tanners treated with naltrexone (2).
Substance dependence diagnostic criteria based on the DSM-IV-TR (3) and the Cut Down, Annoyed, Guilt, Eye-opener (CAGE) Questionnaire for alcoholism (4) have been modified to assess TD (5). The prevelance of TD varies based on the scale used and the population studied. For example, among 229 college-age indoor tanners, 30.6% met the modified CAGE (mCAGE) criteria for TD, 39.3% met the modified DSM-IV-TR (mDSM-IV-TR) criteria, and 21.8% met the criteria on both scales (6) compared to a college-age sample not selected for tanning history or race, among whom only 11% and 23% of 400 individuals were dependent based on the mCAGE and the mDSM-IV-TR, respectively (7).
Alcohol dependence, nicotine dependence and illicit-substance-use disorders have been shown to have a heritable component and to be influenced by genetic factors (8). If TD is similar to these other dependencies, a heritable component is likely.
Questions Addressed
We sought to identify specific TD risk alleles by conducting an exome-wide association study using a panel of ~319,000 single-nucleotide polymorphisms (SNPs), primarily within protein coding regions of the genome. We also conducted a candidate gene analysis of genes previously associated with substance dependence traits (i.e., POMC, ARVCF, COMT, GABRA2, OPRM1, OPRK1, CHRNA3, CHRNA5, ANKK1, and ADH1B) to assess their associations with TD.
Experimental Design
Study Population
The parent study for this analysis, a case-control study of early-onset basal cell carcinoma among English speaking individuals under age 40 (9, 10), was specifically designed to assess the role of indoor tanning and various lifestyle and genetic factors in early-onset skin cancer. For these analyses, a subset of participants from the parent study completed an online survey of TD. A total of 548 eligible subjects completed the online survey (81.9% response rate).
Individuals who reported volitional sunbathing or indoor tanning completed three TD scales to assess lifetime TD: the modified CAGE (5, 11), the modified DSM-IV-TR (5, 11), and the Indoor Tanning Affect and Pathology Scale (iTAPS), a new scale developed by one of the authors (JS) to capture dependence symptoms specifically suggestive of an opioid-like model of TD (i.e., loss of control, craving, withdrawal, stress relief, and mood enhancement related to tanning) (2). Participants were classified as TD if they were positively identified as TD on all three TD scales (n = 79) or not TD if they were negative for TD on all three scales (n = 213). This restrictive classification based on multiple scales was used to identify the most homogeneous phenotypes (TD vs. not TD) and increase power. See Figure S1 for the flow of participants in the study.
DNA from saliva samples was quantified using a Hoefer DyNA Quant 200 fluorometer and arrayed at a concentration of 10 ng/µl for analysis on Axiom Exome 319 Array Plates from Affymetrix (http://www.affymetrix.com).
Results
In the exome-wide analysis, one gene, Patched Domain Containing 2 (PTCHD2), yielded a statistically significant p-value of 2.5×10−6 on the gene-based burden analysis after Bonferroni correction (OR = 0.27) (Table 1). We observed significantly fewer individuals who were TD with a minor allele in this gene compared to individuals who were classified as not TD. Details of the variants are shown in Table S1.
Table 1.
Genes with the strongest association with tanning dependence (TD) resulting from a gene-based analysis of rare and common variants
Gene | TD1 (n=79) n (%) |
Not TD1 (n=213) n (%) |
P-value for Fisher’s Exact Test |
---|---|---|---|
PTCHD2 | 32 (40.5) | 152 (71.4) | 2.50E-06 |
ALDH1B1 | 36 (45.6) | 149 (70.0) | 1.99E-04 |
INHBC | 18 (22.8) | 98 (46.0) | 2.75E-04 |
MYLK3 | 38 (48.1) | 153 (71.8) | 2.80E-04 |
SMC5 | 41 (51.9) | 61 (28.9) | 3.07E-04 |
PRPH2 | 50 (63.3) | 87 (40.8) | 9.05E-04 |
Number having one or more minor alleles at a missense, non-sense or splice site SNP within the gene
Aldehyde dehydrogenase 1 family, member B1 ALDH1B1 was the second highest gene associated with TD; the association was not statistically significant with correction for multiple comparisons. Other top genes in the gene burden analysis are presented in Table 1.
Of the 35 SNPs which passed QC and had a MAF greater than 0.01 in the ten genes in the candidate gene analysis, four SNPs had a p-value less than 0.05; none reached statistical significance following correction for multiple comparisons (Table 2).
Table 2.
Association (p<0.05) with tanning dependence of SNPs within and around substance dependence candidate genes
Gene | SNP | Chromosome | BP | OR1 | P-value1 | AA Change |
---|---|---|---|---|---|---|
OPRM1 | rs650662 | 6 | 154198159 | 0.61 | 0.0181 | upstream |
ANKK1 | rs7118900 | 11 | 113266821 | 1.86 | 0.0131 | Ala239Thr |
ANKK1 | rs4938016 | 11 | 113270015 | 0.62 | 0.0264 | Gly442Arg |
ANKK1 | rs2587543 | 11 | 113279119 | 0.65 | 0.0431 | downstream |
From logistic regression model adjusted for age and sex.
No individual SNP surpassed the Bonferroni corrected exome-wide significance threshold, but the most significant single SNP, rs861204, a missense variant mapped to transmembrane (C-terminal) protease, serine 12 (TMPRSS12), had a p-value of 4.10×10−5 (OR=2.29). All SNPs with a p-value less than 0.0005 are also shown in Table S3.
Conclusions
We evaluated a panel of over 300,000 rare and common exomic variants in this first, large-scale, unbiased association study of TD, and identified one gene (PTCHD2) that met exome-wide significance for TD. PTCHD2 is a gene of unknown function whose product is expressed mainly in the brain. In our candidate gene analysis, three of four SNPs within the Ankyrin Repeat and Kinase Domain Containing 1 (ANKK1) gene had a p<0.05. This gene has repeatedly been shown to be strongly associated with substance and alcohol dependence (12–14), and very recently been reported to be associated with ever (versus never) indoor tanning, however TD was not assessed in that study (15).
A suggested mechanism for TD involves UV-induced p53 protein expression, which results in increased levels of beta-endorphin and adrenocorticotrophic hormone, via stimulation of the pro-opiomelanocortin (POMC) gene promoter (16). With several studies supporting this mechanism (2, 17–19), the nominally-significant association we observed with a SNP in the Opioid Receptor, Mu 1 gene (OPRM1), which encodes the main target of naltrexone, is of possible interest. However, our data do not lend support to the hypothesis that SNPs in the POMC gene are associated with TD (all p-values > 0.25), in contrast to to findings from substance dependence studies (20), although our sample size is comparatively small.
These results are provocative in suggesting genetic associations with TD, but due to the relatively small sample size, replication in larger samples is necessary.
Supplementary Material
Acknowledgements
We would like to acknowledge Peter Spain from the Yale School of Public Health, for his assistance with the coordination and conduct of this project. We are indebted to the individuals who participated in this study.
The studies have been performed according to the Declaration of Helsinki, and have been approved by Yale University’s Institutional Review Board. Subjects provided written informed consent.
Funding/Support: This study was supported in part by NIH/NCI: R21 CA155952 and P50 CA121974
Footnotes
Conflict of Interest: None of the authors have any financial disclosure or conflict of interest to report.
Author contributions:
BC, JG, SM and AB were responsible for the study concept and design. BC and LF were responsible for the acquisition of survey data. AB was responsible the genetic analysis. AD, LF and BC were responsible for data analysis. BC drafted the manuscript. AD, LF, JG, JS, SM and AB provided critical revision of the manuscript for important intellectual content. All authors critically reviewed content and approved final version for publication.
References
- 1.Cartmel B, Ferrucci LM, Spain P, et al. Indoor tanning and tanning dependence in young people after a diagnosis of basal cell carcinoma. JAMA Dermatol. 2013;149:1110–1111. doi: 10.1001/jamadermatol.2013.5104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB, Jr, Feldman SR. Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. Journal of the American Academy of Dermatology. 2006;54:709–711. doi: 10.1016/j.jaad.2005.11.1059. [DOI] [PubMed] [Google Scholar]
- 3.American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. Washington, D.C.: American Psychiatric Association; 2000. [Google Scholar]
- 4.Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131:1121–1123. doi: 10.1176/ajp.131.10.1121. [DOI] [PubMed] [Google Scholar]
- 5.Warthan MM, Uchida T, Wagner RF., Jr. UV light tanning as a type of substance-related disorder. Arch Dermatol. 2005;141:963–966. doi: 10.1001/archderm.141.8.963. [DOI] [PubMed] [Google Scholar]
- 6.Mosher CE, Danoff-Burg S. Addiction to indoor tanning: relation to anxiety, depression, and substance use. Arch Dermatol. 2010;146:412–417. doi: 10.1001/archdermatol.2009.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Heckman CJ, Egleston BL, Wilson DB, Ingersoll KS. A preliminary investigation of the predictors of tanning dependence. American journal of health behavior. 2008;32:451–464. doi: 10.5555/ajhb.2008.32.5.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wang JC, Kapoor M, Goate AM. The genetics of substance dependence. Annu Rev Genomics Hum Genet. 2012;13:241–261. doi: 10.1146/annurev-genom-090711-163844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ferrucci LM, Cartmel B, Molinaro AM, et al. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma. J Invest Dermatol. 2012;132:1272–1279. doi: 10.1038/jid.2011.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Indoor tanning and risk of early-onset basal cell carcinoma. J Am Acad Dermatol. 2012;67:552–562. doi: 10.1016/j.jaad.2011.11.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Harrington CR, Beswick TC, Leitenberger J, Minhajuddin A, Jacobe HT, Adinoff B. Addictive-like behaviours to ultraviolet light among frequent indoor tanners. Clin Exp Dermatol. 2011;36:33–38. doi: 10.1111/j.1365-2230.2010.03882.x. [DOI] [PubMed] [Google Scholar]
- 12.Gelernter J, Yu Y, Weiss R, et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet. 2006;15:3498–3507. doi: 10.1093/hmg/ddl426. [DOI] [PubMed] [Google Scholar]
- 13.Nelson EC, Lynskey MT, Heath AC, et al. ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure. JAMA Psychiatry. 2013;70:325–333. doi: 10.1001/jamapsychiatry.2013.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res. 2008;32:2117–2127. doi: 10.1111/j.1530-0277.2008.00800.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Flores KG, Erdei E, Luo L, et al. A pilot study of genetic variants in dopamine regulators with indoor tanning and melanoma. Exp Dermatol. 2013;22:576–581. doi: 10.1111/exd.12200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Fisher DE, James WD. Indoor tanning--science, behavior, and policy. N Engl J Med. 2010;363:901–903. doi: 10.1056/NEJMp1005999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kaur M, Liguori A, Fleischer AB, Jr, Feldman SR. Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli. J Am Acad Dermatol. 2006;54:919–920. doi: 10.1016/j.jaad.2006.01.062. [DOI] [PubMed] [Google Scholar]
- 18.Feldman SR, Liguori A, Kucenic M, et al. Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. Journal of the American Academy of Dermatology. 2004;51:45–51. doi: 10.1016/j.jaad.2004.01.053. [DOI] [PubMed] [Google Scholar]
- 19.Harrington CR, Beswick TC, Graves M, et al. Activation of the mesostriatal reward pathway with exposure to ultraviolet radiation (UVR) vs. sham UVR in frequent tanners: a pilot study. Addict Biol. 2012;17:680–686. doi: 10.1111/j.1369-1600.2010.00312.x. [DOI] [PubMed] [Google Scholar]
- 20.Zhang H, Kranzler HR, Weiss RD, et al. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry. 2009;66:128–136. doi: 10.1016/j.biopsych.2008.12.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.